Venlafaxine-induced acute eosinophilic pneumonia

Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):411.e7-9. doi: 10.1016/j.genhosppsych.2011.03.010. Epub 2011 May 5.

Abstract

Introduction: Acute Eosinophilic Pneumonia (AEP) is a severe syndrome which can be potentially induced by many reasons, including drugs. It is characterized by pulmonary infiltrates, peripheral blood eosinophilia and respiratory failure. AEP has rarely been associated with antidepressant treatment.

Case report: We report a case of an 80-year-old woman who presented with fever, lung infiltrates, peripheral blood eosinophilia and acute respiratory failure. All evidence charge venlafaxine as the only possible causal factor. The syndrome rapidly resolved after discontinuation of the drug and upon reception of corticosteroids in low doses. The patient had a past medical history of AEP induced by sertraline and a recent medical history of Acute Lung Injury on the context of acute pancreatitis during treatment with venlafaxine.

Discussion: Pathophysiological mechanisms implicated in the development of AEP in our patient seems to be associated with eotaxin and serotonin eosinophilic-specific chemoattracting action.

Conclusion: This is a case report with clinical adverse reaction of AEP in two antidepressant agents (venlafaxine and sertraline) with a similar neurochemical mechanism of action via the serotoninergic system.

Publication types

  • Case Reports

MeSH terms

  • Acute Lung Injury
  • Aged, 80 and over
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Cyclohexanols / administration & dosage
  • Cyclohexanols / adverse effects*
  • Cyclohexanols / therapeutic use
  • Female
  • Greece
  • Humans
  • Outcome Assessment, Health Care
  • Pulmonary Eosinophilia / chemically induced*
  • Pulmonary Eosinophilia / physiopathology
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Venlafaxine Hydrochloride